Clinical Trial Update: A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis [Phase 2]

View source ↗

Summary

Phase II clinical trial update for STSP-0902 ophthalmic solution in neurotrophic keratitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• STSP-0902 ophthalmic solution

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Neurotrophic Keratitis | Phase 2 | Status: RECRUITING